Intercytex Group Plc has announced the all-share acquisition of Axordia Ltd, a privately-held UK stem cell company, for £1.68 million. Announced on 22 December 2008, the deal will expand Intercytex’s regenerative medicines’ business into stem cell therapies in addition to its focus on tissue repair.
